Repository logo
 
Publication

Longitudinal assessment of migraine burden in resistant and refractory migraine – data from the prospective REFINE study

dc.contributor.authorPensato, Umberto
dc.contributor.authorOrnello, Raffaele
dc.contributor.authorRosignoli, Chiara
dc.contributor.authorCaponnetto, Valeria
dc.contributor.authorOnofri, Agnese
dc.contributor.authorBraschinsky, Mark
dc.contributor.authorSved, Olga
dc.contributor.authorGil-Gouveia, Raquel
dc.contributor.authorOliveira, Renato
dc.contributor.authorLampl, Christian
dc.contributor.authorPaungarttner, Jakob
dc.contributor.authorMartelletti, Paolo
dc.contributor.authorWells-Gatnik, William David
dc.contributor.authorMartins, Isabel Pavao
dc.contributor.authorMitsikostas, Dimos D.
dc.contributor.authorApostolakopoulou, Loukia
dc.contributor.authorOzge, Aynur
dc.contributor.authorNarin, Dilan Bayar
dc.contributor.authorPozo-Rosich, Patricia
dc.contributor.authorMunoz-Vendrell, Albert
dc.contributor.authorPrudenzano, Maria Pia
dc.contributor.authorGentile, Martino
dc.contributor.authorRyliskiene, Kristina
dc.contributor.authorVainauskiene, Jurgita
dc.contributor.authorSanchez-del-Rio, Margarita
dc.contributor.authorVernieri, Fabrizio
dc.contributor.authorIaccarino, Gianmarco
dc.contributor.authorWaliszewska-Prosół, Marta
dc.contributor.authorBudrewicz, Sławomir
dc.contributor.authorCarnovali, Marta
dc.contributor.authorKatsarava, Zaza
dc.contributor.authorSacco, Simona
dc.date.accessioned2025-09-08T10:57:57Z
dc.date.available2025-09-08T10:57:57Z
dc.date.issued2025-12-01
dc.description.abstractBackground: Some individuals with migraine fail to respond adequately to preventive treatments, bearing most of migraine burden. The European Headache Federation (EHF) classifies these individuals into resistant migraine (ResM) or refractory migraine (RefM) according to treatment failures, debilitating headache days, and disease duration. We investigated the evolution of these categories over six months in patients treated at tertiary headache centers and whether they accurately reflect disability and burden. Methods: Participants from the multicenter, prospective REFINE study were classified into three categories of treatment responsiveness, namely RefM, ResM, and non-refractory non-resistant migraine (NRNRM). The primary objective was to determine the trajectories of category changes over six months. Secondary outcomes included changes in the 6-item Headache Impact Test (HIT-6), Headache-Attributed Lost Time (HALT), and Hospital Anxiety and Depression Scale (HADS-A and HADS-D) scores. Results: Overall, 489 participants were included with a median age of 45 years (IQR = 36–53); 389 participants (79.7%) were female; 256 (52.4%) had NRNRM, 178 (36.4%) ResM, and 55 (11.2%) RefM. At follow-up, 200/256 (78.1%) NRNRM remained stable, while 56/256 (21.9%) progressed to ResM. Among those with ResM, 98/178 (55.1%) remained stable, 72/178 (40.5%) improved to NRNRM, and 8/178 (4.5%) worsened to RefM. Among participants with RefM, 37/55 (67.3%) remained stable, while 18/55 (32.7%) improved to NRNRM. Participants with RefM and ResM presented significantly higher scores at baseline than those with NRNRM. Over time, HIT-6, HALT, and HADS-A scores improved substantially in the overall cohort (p < 0.001, p < 0.001, and p = 0.006, respectively). Improvements were observed in participants with ResM across all scores and HIT-6 and HALT for NRNRM, but no improvement was noted in participants with RefM. Conclusions: Over six months, ~ 40% of ResM and ~ 30% of RefM individuals improved to NRNRM, while ~ 20% of NRNRM developed treatment resistance after receiving care in tertiary headache centers. Participants with ResM had a better prognosis than those with RefM. While both ResM and RefM reflect high migraine disability burden, they might present relevant differences in their management and prognosis.eng
dc.identifier.citationPensato, U., Ornello, R., Rosignoli, C., & Caponnetto, V. et al. (2025). Longitudinal assessment of migraine burden in resistant and refractory migraine – data from the prospective REFINE study. Journal of Headache and Pain, 26(1), Article 184. https://doi.org/10.1186/s10194-025-02126-9
dc.identifier.doi10.1186/s10194-025-02126-9
dc.identifier.eid105013286083
dc.identifier.issn1129-2369
dc.identifier.othercaf34c3f-8c0f-4e06-949f-625ea90c2c06
dc.identifier.pmcPMC12355733
dc.identifier.pmid40817153
dc.identifier.urihttp://hdl.handle.net/10400.14/54739
dc.identifier.wos001551650300001
dc.language.isoeng
dc.peerreviewedyes
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAnti-CGRP
dc.subjectChronic migraine
dc.subjectDisability
dc.subjectGepants
dc.subjectHeadache
dc.subjectIntractable
dc.subjectMonoclonal antibodies
dc.subjectValidation
dc.titleLongitudinal assessment of migraine burden in resistant and refractory migraine – data from the prospective REFINE studyeng
dc.typeresearch article
dspace.entity.typePublication
oaire.citation.issue1
oaire.citation.titleJournal of Headache and Pain
oaire.citation.volume26
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
127383279.pdf
Size:
2.64 MB
Format:
Adobe Portable Document Format